Repository logo
Home
Research Outputs
Collections
Statistics
Shared Repository Homepage
  1. Home
  2. Cultural Heritage Shared Repository Service
  3. Royal Botanic Gardens, Kew
  4. Article
  5. Antioxidant Delivery Revisited: The Promise of Nanostructured Lipid Carriers.

Antioxidant Delivery Revisited: The Promise of Nanostructured Lipid Carriers.

Thumbnail Image
Download
Name

medicines-13-00002.pdf

Description
visibility:open
Size

800.56 KB

Format

Adobe PDF

Checksum (CRC64NVME)

CSrPFJgE8s4=

Resource type
Journal article
Creator (person)
Behar, Leif
Siddique, Holly
Date published
January 21, 2025
Abstract
Natural products have an invaluable therapeutic effect on human health. Natural antioxidants, including beta-carotene, turmeric, and polyphenols, are recognised for their health benefits but face significant barriers related to insufficient solubility, instability, volatility, and diminished bioavailability, which limit their therapeutic efficacy in drug delivery systems. Therefore, encapsulation of natural products in a carrier addresses the above concern. Drug delivery systems, such as solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs), are promising carriers for effective release, consisting of solid and liquid lipids, which enhance efficiency, stability, and controlled release, thereby minimising bioavailability limitations. This review consolidates current studies on the formulation methodologies, mechanisms of action, and therapeutic applications of NLCs, emphasizing their use in the treatment of conditions such as cancer, neurological disorders, and cardiovascular diseases. The results demonstrate that NLCs substantially enhance the bioavailability and therapeutic efficacy of antioxidants, thereby improving their targeted administration and clinical effects. Nonetheless, difficulties in clinical translation remain, including drug loading capacity, regulatory authorisation, and the need for pervasive research on cytotoxicity. This article highlights important areas for future inquiry, specifically the optimisation of NLC formulations, the enhancement of targeting accuracy, and the resolution of safety issues to enhance their clinical application.
Journal title
Medicines
Volume
13
Issue
1
Article number
2
Publisher
MDPI AG
Place of publication
Basel, Switzerland
eISSN
2305-6320
Date accepted
January 15, 2025
Official URL
https://doi.org/10.3390/medicines13010002
Related URL
https://www.mdpi.com/2305-6320/13/1/2
Rights statement
In Copyright
Licence
https://creativecommons.org/licenses/by/4.0/
DOI
10.3390/medicines13010002
Keywords
Natural compounds
Antioxidant delivery
Neurodegenerative diseases
Nanostructured lipid carriers (NLCs)
Cancer treatment
Therapeutic applications
Controlled release
Bioavailability enhancement
Polyphenols
Drug delivery systems
Additional information
IF = unknown.
Managed by the British Library and supported by the AHRC

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • End User Agreement
  • About
  • Contact
  • Help
Repository logo COAR Notify